原发性骨质疏松症中西医结合治疗现状及研究进展

摘要

骨质疏松症是以骨强度下降罹患骨折危险性增加为特征的骨骼系统疾病,被称为“静悄悄的流行病”、是吞噬老年人健康的“隐形杀手”,医学界已将防治骨质疏松预防骨折、治疗高血压预防中风、治疗高血脂预防心肌埂塞这三种疾病放在同样重要的位置.随着我国人口结构老龄化的加剧,骨质疏松症(osteoporosis,op)的发病率呈逐年上升的趋势.原发性骨质疏松症是一种老年人常见的全身性骨病,女性较男性多见,常见于绝经后妇女和老年人,主要包括Ⅰ型绝经后骨质疏松症和Ⅱ型老年性骨质疏松症.近年来,原发性骨质疏松症的中西医治疗已经取得了显著的进步,中西医结合治疗骨质疏松症成为未来研究的新趋势.作者就中西医综合治疗原发性骨质疏松症的现状及其研究进展做以综述.%Osteoporosis is a systemic skeletal disease,characterized by reduced bone strength and increased risk for fractures,which is known as the "silent epidemic" and the "invisible killer" of old people which taken away the health of the elderly.The medical profession has put the three diseases,including the prevention and treatment of osteoporosis and the prevention of fracture,the treatment of high blood pressure and the prevention of stroke,the treatment of hyperlipidemia and the prevention of myocardial infraction,of equal importance.Along with our country entering into an ageing population,the incidence of osteoporosis (OP) rises year by year.Primary osteoporosis is a systemic bone disease common in the elderly,more common in women than men,and is common in postmenopausal women and the elderly,mainly includes type Ⅰ postmenopausal osteoporosis and type Ⅱ senile osteoporosis.In recent years,the treatment of osteoporosis has made significant progress,Chinese and Western medicine combined treatment for osteoporosis has become the new trend for future research.In this article,the current status and research progress of traditional Chinese and Western medicine combined treatment for primary osteoporosis were summarized.